Tumor Thrombectomy Without Bypass for Low-Grade Malignant Tumors Extending into the Inferior Vena Cava: Report of Two Cases

Surgery Today ◽  
2006 ◽  
Vol 36 (5) ◽  
pp. 465-469 ◽  
Author(s):  
Masatoshi Jibiki ◽  
Yoshinori Inoue ◽  
Norihide Sugano ◽  
Takehisa Iwai ◽  
Tomoyasu Katou
Keyword(s):  
Inferior Vena Cava ◽  
Inferior Vena ◽  
Malignant Tumors ◽  
Vena Cava ◽  
Low Grade

scholarly journals Intracardiac extension of the inferior vena cavaLeiomyosarcoma with Budd-Chiari syndrome presentation: A case report

2015 ◽  
Vol 143 (1-2) ◽  
pp. 71-73
Author(s):  
Predrag Matic ◽  
Goran Vucurevic ◽  
Srdjan Babic ◽  
Slobodan Tanaskovic ◽  
Branko Lozuk ◽  
...  
Keyword(s):  
Inferior Vena Cava ◽  
Inferior Vena ◽  
Malignant Tumors ◽  
Vena Cava ◽  
Complete Removal ◽  
Term Result ◽  
Short Term ◽  
Short Term Result ◽  
Chiari Syndrome ◽  
Intracardiac Extension

Introduction. Leiomyosarcomas of the inferior vena cava are rare malignant tumors. A limited number of these cases have been described so far. Only few of them have intracardiac propagation and surgery is rarely undertaken for their treatment. Case Outline. We present a 52-year-old female patient in whom leiomyosarcoma of the inferior vena cava with intracardiac propagation was diagnosed. The patient underwent successful surgical treatment with complete removal of the tumor and direct suture of the inferior vena cava. No additional modalities of therapy were undertaken. Conclusion. Surgery, without radiation therapy can be a successful option for the treatment of inferior vena cava leiomyosarcoma with a good short-term result.

scholarly journals Low-Grade Endometrial Stromal Sarcoma with Inferior Vena Cava Extension: First Report in Korea

2014 ◽  
Vol 30 (3) ◽  
pp. 98-101 ◽  
Author(s):  
Mi-Hyeong Kim ◽  
Chan-Kwon Jung ◽  
Jeong-Kye Hwang ◽  
In-Sung Moon ◽  
Ji-Il Kim
Keyword(s):  
Inferior Vena Cava ◽  
Inferior Vena ◽  
Vena Cava ◽  
Endometrial Stromal Sarcoma ◽  
Low Grade ◽  
First Report ◽  
Stromal Sarcoma

scholarly journals Low-Grade Endometrial Stromal Sarcoma with Intravenous and Intracardiac Extension: A Case Report

2020 ◽  
Author(s):  
Xiaoshan Chai ◽  
Hui Ding ◽  
Peng Zhou ◽  
Xilong Mei ◽  
XiaoXue Li ◽  
...  
Keyword(s):  
Inferior Vena Cava ◽  
Right Atrium ◽  
Inferior Vena ◽  
Vena Cava ◽  
Pelvic Mass ◽  
Endometrial Stromal Sarcoma ◽  
Iliac Vein ◽  
Low Grade ◽  
Ki 67 ◽  
Stromal Sarcoma

Abstract Background: Low-grade endometrial stromal sarcoma (ESS) is rare mesenchymal neoplasm, which has an indolent history with late recurrences. ESS usually spread through the lymph nodes and venous system but very seldom involve large vessels or the heart.Case presentation: A 38-year-old Chinese woman was admitted to our department due to pelvic mass found on physical examination. The superior and inferior vena cava CT angiography (CTA) showed an enlarged uterine as well as low density image in the left internal iliac vein, the left common iliac vein, the inferior vena cava, the left renal vein adjacent to the heart and the right atrium, with a range of 110*16mm. The filling defect of right atrium was about 30*14mm. The three-dimensional computed tomography reconstruction showed that the mass originated from the uterine and invaded into the reproductive vein, subsequently extended along the inferior vena cava to the right atrium. Needle biopsy of the pelvic mass was performed and the tissue indicates smooth muscle. The preoperative diagnosis was intravascular leiomyomatosis and the patient underwent radical resection: thrombectomy and total hysterectomy with bilateral salpingo-oophorectomy. Postoperative histopathology revealed low grade endometrial stromal sarcoma. Microscopically, the tumors in both original uterine lesions and intravascular and intracardiac metastases shared morphologic features characterized by neoplastic cells similar to proliferative-phase endometrial stromal cells, in which small spiral artery differentiation was recognized and tumor tissue showed invasive growth pattern by inserting into the surrounding smooth muscle. Immunohistochemistry showed tumor cells were reactive to Estrogen Receptor, Progesterone Receptor,CD10. Primary uterine foci showed cyclin D1(5%+) and Ki-67(20%+),whereas metastatic lesions of the intracardiac and the intravascular component identified cyclin D1(negative) and Ki-67(2%+). The patient is alive without evidence of recurrence 3 months after surgery.Conclusions: Distant metastasis of low-grade endometrial stromal sarcoma is rare, especially involving large vessels or the heart. This case demonstrates that malignant tumor metastasis should be considered as a differential diagnosis of intracardiac and intravascular masses. The treatment rely on multidisciplinary cooperation.

Single Institution Experience with Inferior Vena Cava Filters.

Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 914-914
Author(s):  
Nikhil Bhalla ◽  
Anca Bulgaru ◽  
Lynn Church ◽  
Dinesh Kapur ◽  
Herb Lustberg ◽  
...  
Keyword(s):  
High Risk ◽  
Inferior Vena Cava ◽  
Inferior Vena ◽  
Vena Cava ◽  
Low Grade ◽  
Ivc Filter ◽  
Ivc Filters ◽  
Additional Surgery ◽  
Clot Burden ◽  
Retrievable Ivc Filters

Abstract Inferior vena cava (IVC) filters are used in patients (pts.) with Deep Venous Thrombosis (DVT) to prevent pulmonary embolism (PE) when anticoagulation cannot be administered. The purpose of this study was to analyze the use and outcomes of IVC filters in a community hospital. We reviewed the medical records of all pts. who had IVC filters implanted at William W. Backus Hospital between May 2003 and May 2005. Follow up information was obtained up to August 2005 by mailings from the attending physicians. 125 IVC filters were implanted in 121 pts., ages 18 to 93, with 61 males and 60 females. The indications for implantation were contraindication as follows: to anticoagulation in 72 pts. (58%), up coming surgical procedures in 33 pts. (26%), and severity of clot burden in 20 pts. (16%). 123 (98%) filters were deployed into an infrarenal position and 2 into a suprarenal position due to extensive clot in the IVC. Of the 105 filters that were not retrieved 60 were Gunther Tulip (GT) retrievable IVC filters, 42 were Cordis Trapease (CT) permanent IVC filters, 2 were stainless steel Greenfield IVC filters, and 1 was a Cordis Optease (CO) IVC filter. Of the 20 retrieved filters 19 were GT retrievable IVC filters and 1 was a CO IVC filter. Of the 125 filters, 74 were intended to be permanent filters (59%) and 51 (41%) were inserted with intention of retrieval. 31/51 (60%) were eventually not retrieved because of various reasons: need for additional surgery (12), poor pulmonary reserve (5), high-risk of bleeding (5), severity of clot burden (4), short life expectancy (4), and extremely high risk of recurrent DVT (1). Short-term and long-term anticoagulation was used in conjunction with the IVC filters in 21 and 81 pts. respectively. 38 (31%) of the 121 pts. experienced recurrent venous thromboembolism (VTE), 37 developed symptomatic DVT and 1 had a symptomatic PE. 3/20 (15%) of the pts. who had their filters retrieved developed recurrent DVT (18, 22, and 76 days after filter retrieval) compared with 34/105 (32%) pts. who had permanent filters. The only objectively documented symptomatic PE occurred in a pt. with a permanent filter. This pt. had a recurrent PE 7 months post GT IVC filter insertion diagnosed by chest CT scan with PE protocol. Complications were as follows: 1 pt. had transient hypertension immediately after IVC insertion and 1 pt. developed a transient low-grade fever after retrieval. 1 pt. developed retroperitoneal hematoma upon retrieval 75 days after implantation as documented by an IVC Gram and this pt. recovered without need for any intervention and there were no adverse clinical consequences. The implantation periods ranged from 2 to 104 days in the 20 retrieved filters with mean/median of 20/9 days. 4 of the 20 retrieved filters (20%) contained trapped emboli and none of these pts. subsequently developed PE. The GT retrievable IVC filter is now the filter of choice at our institution and can be implanted permanently or with retrieval in mind. Conclusion: Retrievable filters were removed up to 104 days post insertion in this series of pts. and the incidence of complications was negligible. Retrievable IVC filters may be substituted for permanent IVC filters to preserve the option of retrieval, and retrieval of filters beyond 3 months post implantation is feasible and should be studied further.

scholarly journals 125I Brachytherapy Seeds Implantation for Inoperable Low-Grade Leiomyosarcoma of Inferior Vena Cava

2013 ◽  
Vol 14 (2) ◽  
pp. 278 ◽  
Author(s):  
Yuliang Li ◽  
Yongzheng Wang ◽  
Bin Liu ◽  
Zheng Li ◽  
Wujie Wang
Keyword(s):  
Inferior Vena Cava ◽  
Inferior Vena ◽  
Vena Cava ◽  
Low Grade ◽  
125I Brachytherapy

scholarly journals Sintilimab plus sorafenib: a novel regimen for hepatocellular carcinoma

Immunotherapy ◽  
2021 ◽  
Author(s):  
Xuhong Liu ◽  
Yong Yi
Keyword(s):  
Hepatocellular Carcinoma ◽  
Inferior Vena Cava ◽  
Right Atrium ◽  
Tumor Thrombus ◽  
Inferior Vena ◽  
Malignant Tumors ◽  
Lung Metastases ◽  
Antiangiogenic Therapy ◽  
Vena Cava ◽  
New Treatments

Hepatocellular carcinoma is one of the most common malignant tumors in China and is also a major cause of cancer deaths worldwide. Recent advances in immunotherapy have identified new treatments in which immunotherapy can be combined with antiangiogenic therapy. We report a case of hepatocellular carcinoma with a tumor thrombus at the inferior vena cava–right atrium junction and multiple lung metastases after a multiple-course treatment. Treatment with sintilimab in combination with sorafenib led to a partial remission and immune-related hepatitis.

CIRCUMFERENTIAL RESECTION OF THE INFERIOR VENA CAVA FOR PRIMARY AND RECURRENT MALIGNANT TUMORS

2009 ◽  
Vol 181 (4S) ◽  
pp. 744-744
Author(s):  
Jorge R Caso ◽  
John D Seigne ◽  
Martin Back ◽  
Julio Pow Sang ◽  
Philippe E Spiess ◽  
...  
Keyword(s):  
Inferior Vena Cava ◽  
Inferior Vena ◽  
Malignant Tumors ◽  
Vena Cava

scholarly journals CLINICAL CONSIDERATION CONCERNING SURGICAL TREATMENT FOR MALIGNANT TUMORS EXTENDING INTO THE HEPATIC INFERIOR VENA CAVA

1990 ◽  
Vol 51 (11) ◽  
pp. 2405-2411
Author(s):  
Masaru MIYAZAKI ◽  
Takashi KAIHO ◽  
Ikuo UDAGAWA ◽  
Hisao KOSHIKAWA ◽  
Katsuhiro IINUMA ◽  
...  
Keyword(s):  
Surgical Treatment ◽  
Inferior Vena Cava ◽  
Inferior Vena ◽  
Malignant Tumors ◽  
Vena Cava ◽  
Clinical Consideration

Should the inferior vena cava be reconstructed after resection for malignant tumors?

2005 ◽  
Vol 189 (4) ◽  
pp. 419-424 ◽  
Author(s):  
Hiroyuki Yoshidome ◽  
Dan Takeuchi ◽  
Hiroshi Ito ◽  
Fumio Kimura ◽  
Hiroaki Shimizu ◽  
...  
Keyword(s):  
Inferior Vena Cava ◽  
Inferior Vena ◽  
Malignant Tumors ◽  
Vena Cava
Sign in / Sign up

Export Citation Format

Share Document